Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TERN PLC Investor Presentation 2026

Jan 8, 2026

7958_rns_2026-01-08_bb1dd731-5337-4733-9136-1eaae120c0bc.html

Investor Presentation

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0746O

Tern PLC

08 January 2026

8 January 2026

Tern Plc

("Tern" or the "Company")

Investor Presentations

Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, is pleased to announce that following its online presentation and a Q&A session yesterday evening involving Tern's portfolio companies Device Authority and Talking Medicines, copies of the presentations from the participating companies can be found via the links below:

Device Authority presentation:  http://www.rns-pdf.londonstockexchange.com/rns/0746O_1-2026-1-7.pdf

Talking Medicines presentation:  http://www.rns-pdf.londonstockexchange.com/rns/0746O_2-2026-1-7.pdf

In addition a recording of the event will shortly be available to view on the Company's website at: https://www.ternplc.com/resources

Enquiries

Tern Plc

Jane McCracken (Interim Non-Executive Chair)
via IFC Advisory
Allenby Capital Limited

(Nominated Adviser and Broker)

Alex Brearley / Ashur Joseph (Corporate Finance)

Kelly Gardiner (Sales and Corporate Broking)
Tel: 0203 328 5656
IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Staton
Tel: 0203 934 6632

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCBRMLTMTAMBRF